[Long-term treatment of medullary insufficiency with androgens].
D000236:Adenoma / Q000139:chemically induced; D000328:Adult; D000728:Androgens / Q000627:therapeutic use*; D001803:Blood Transfusion; D001855:Bone Marrow Diseases / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006128:Growth / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007223:Infant; D008297:Male; D009277:Nandrolone / Q000494:pharmacology; D011471:Prostatic Neoplasms / Q000139:chemically induced; D013197:Stanozolol / Q000009:adverse effects / Q000494:pharmacology; D013739:Testosterone / Q000009:adverse effects / Q000494:pharmacology; D013997:Time Factors; D014770:Virilism / Q000139:chemically induced
D000728:Androgens; D013739:Testosterone; D013197:Stanozolol; D009277:Nandrolone
Bilancio a lunga scadenza nel trattamento con androgeni delle insufficienze midollari.